Team:NTU-Taida/Project/Future-Plan
From 2012.igem.org
Line 1: | Line 1: | ||
{{:Team:NTU-Taida/Templates/Header}}{{:Team:NTU-Taida/Templates/Navbar}}{{:Team:NTU-Taida/Templates/Sidebar|Title=Future Plan}}{{:Team:NTU-Taida/Templates/ContentStart}}{{:Team:NTU-Taida/Templates/BSHero|Title=Future Plan|Content=<p></p>}} | {{:Team:NTU-Taida/Templates/Header}}{{:Team:NTU-Taida/Templates/Navbar}}{{:Team:NTU-Taida/Templates/Sidebar|Title=Future Plan}}{{:Team:NTU-Taida/Templates/ContentStart}}{{:Team:NTU-Taida/Templates/BSHero|Title=Future Plan|Content=<p></p>}} | ||
- | = | + | <p style="text-indent: 2em;"> |
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Following are some diseases that can be potentially treated with our PEPDEX systems. Our focus will be put on the immunological diseases, such as '''anti-allergy therapies''' and '''anti-cancer vacicines'''. | ||
+ | </p> | ||
+ | |||
+ | === Neuroscience === | ||
+ | <p style="text-indent: 2em;"> | ||
+ | '''● Neurological diseases''' | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Alzheimer disease (Perry and Greig 2004; Li, Duffy et al. 2010) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Multiple sclerosis (Bielekova et al. 2000; Holz et al. 2000; Jurynczyk et al. 2010) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Parkinson’s disease (Szeto 2006) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Epilesy (Brothers and Wahlestedt 2010) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | '''● Psychiatric diseases''' | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Anxiety disorder (Holmes et al. 2003; Leonard et al. 2008; Steckler 2008; Madaan and Wilson 2009) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Depression (Holmes et al. 2003; Leonard et al. 2008; Madaan and Wilson 2009) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Eating disorder (Brothers and Wahlestedt 2010) | ||
+ | </p> | ||
=== Immunology === | === Immunology === | ||
- | + | <p style="text-indent: 2em;"> | |
+ | '''● Anti-cancer vaccine''' | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Melanoma(Minor 2011; Schwartzentruber, Lawson et al. 2011) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Cervical cancer (Zwaveling, Ferreira Mota et al. 2002) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | '''● Anti-allergy vaccine''' | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Asthma (Campbell, Buckland et al. 2009) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Rheumatoid arthritis (Holgate and Broide 2003) | ||
+ | </p> | ||
+ | <p style="text-indent: 2em;"> | ||
+ | Allergic rhinitis (Larche and Wraith 2005) (Takagi, Hiroi et al. 2005) | ||
+ | </p> | ||
== Immunological therapy == | == Immunological therapy == | ||
+ | <p style="text-indent: 2em;"> | ||
+ | |||
+ | </p> | ||
=== Anti-malignancy === | === Anti-malignancy === | ||
+ | <p style="text-indent: 2em;"> | ||
+ | </p> | ||
== Reference == | == Reference == | ||
+ | <p style="text-indent: 2em;"> | ||
+ | |||
+ | </p> | ||
<!-- EOF --> | <!-- EOF --> | ||
{{:Team:NTU-Taida/Templates/ContentEnd}}{{:Team:NTU-Taida/Templates/Footer|ActiveNavbar=Project, #nav-Project-Future}} | {{:Team:NTU-Taida/Templates/ContentEnd}}{{:Team:NTU-Taida/Templates/Footer|ActiveNavbar=Project, #nav-Project-Future}} |
Revision as of 20:22, 26 October 2012
Future Plan
Following are some diseases that can be potentially treated with our PEPDEX systems. Our focus will be put on the immunological diseases, such as anti-allergy therapies and anti-cancer vacicines.
Contents |
Neuroscience
● Neurological diseases
Alzheimer disease (Perry and Greig 2004; Li, Duffy et al. 2010)
Multiple sclerosis (Bielekova et al. 2000; Holz et al. 2000; Jurynczyk et al. 2010)
Parkinson’s disease (Szeto 2006)
Epilesy (Brothers and Wahlestedt 2010)
● Psychiatric diseases
Anxiety disorder (Holmes et al. 2003; Leonard et al. 2008; Steckler 2008; Madaan and Wilson 2009)
Depression (Holmes et al. 2003; Leonard et al. 2008; Madaan and Wilson 2009)
Eating disorder (Brothers and Wahlestedt 2010)
Immunology
● Anti-cancer vaccine
Melanoma(Minor 2011; Schwartzentruber, Lawson et al. 2011)
Cervical cancer (Zwaveling, Ferreira Mota et al. 2002)
● Anti-allergy vaccine
Asthma (Campbell, Buckland et al. 2009)
Rheumatoid arthritis (Holgate and Broide 2003)
Allergic rhinitis (Larche and Wraith 2005) (Takagi, Hiroi et al. 2005)
Immunological therapy
Anti-malignancy
Reference